Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
!!Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
MT2026-21: A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma (Palisades-1)
Bachanova, Veronika
(PI)
Medicine - Hematology, Oncology, Transplant
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
6/15/26
→
6/30/36
Funding
KITE PHARMA, INC
View all
View less